Exelixis to Release Second Quarter 2024 Financial Results on Tuesday, August 6, 2024
Exelixis (Nasdaq: EXEL) has announced the release date for its second quarter 2024 financial results. The company will disclose its financial performance on Tuesday, August 6, 2024, after the markets close. Following the release, Exelixis management will host a conference call and webcast at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results and provide a general business update.
Interested parties can access the event through the company's website. To join the conference call, registration is required via a provided link, which will furnish a dial-in number and unique PIN. The live webcast can be accessed through the Event Calendar page under the Investors & News section of www.exelixis.com. A replay of the webcast will be available on the company's website for one year.
Exelixis (Nasdaq: EXEL) ha annunciato la data di rilascio dei risultati finanziari del secondo trimestre 2024. L'azienda divulgherà le sue performance finanziarie martedì 6 agosto 2024, dopo la chiusura dei mercati. Dopo il rilascio, la direzione di Exelixis terrà una teleconferenza e webcast alle 17:00 ET / 14:00 PT per discutere i risultati e fornire un aggiornamento generale sull'attività.
Le parti interessate possono accedere all'evento tramite il sito web dell'azienda. Per partecipare alla teleconferenza, è necessaria la registrazione tramite un link fornito, che fornirà un numero da comporre e un PIN unico. Il webcast dal vivo può essere accessibile tramite la pagina del Calendario Eventi nella sezione Investitori & News di www.exelixis.com. Una registrazione del webcast sarà disponibile sul sito dell'azienda per un anno.
Exelixis (Nasdaq: EXEL) ha anunciado la fecha de lanzamiento de sus resultados financieros del segundo trimestre de 2024. La empresa dará a conocer su desempeño financiero el martes 6 de agosto de 2024, después del cierre del mercado. Tras el lanzamiento, la dirección de Exelixis realizará una llamada de conferencia y un webcast a las 5:00 p.m. ET / 2:00 p.m. PT para discutir los resultados y proporcionar una actualización general del negocio.
Las partes interesadas pueden acceder al evento a través del sitio web de la empresa. Para unirse a la llamada de conferencia, se requiere registrarse a través de un enlace proporcionado, que proporcionará un número de marcado y un PIN único. El webcast en vivo se puede acceder a través de la página de Calendario de Eventos en la sección de Inversores & Noticias de www.exelixis.com. Una grabación del webcast estará disponible en el sitio web de la empresa durante un año.
엑셀리시스(나스닥: EXEL)는 2024년 2분기 재무 결과 발표 날짜를 발표했습니다. 이 회사는 2024년 8월 6일 화요일에 시장이 종료된 후 재무 성과를 공개할 예정입니다. 이후 엑셀리시스 경영진은 동부 표준시 오후 5시/태평양 표준시 오후 2시에 결과를 논의하고 일반 비즈니스 업데이트를 제공하는 전화 회의 및 웹캐스트를 개최합니다.
관심 있는 당사자는 회사 웹사이트를 통해 이벤트에 접근할 수 있습니다. 전화 회의에 참여하려면 제공된 링크를 통해 등록이 필요하며, 이를 통해 다이얼인 번호와 고유 PIN을 제공받게 됩니다. 라이브 웹캐스트는 www.exelixis.com의 투자자 및 뉴스 섹션 아래 이벤트 캘린더 페이지를 통해 액세스할 수 있습니다. 웹캐스트의 재생은 회사 웹사이트에서 1년 동안 이용 가능합니다.
Exelixis (Nasdaq: EXEL) a annoncé la date de publication de ses résultats financiers du deuxième trimestre 2024. L'entreprise dévoilera sa performance financière le mardi 6 août 2024, après la clôture des marchés. Suite à la publication, la direction d'Exelixis animera une conférence téléphonique et un webinaire à 17h00 ET / 14h00 PT pour discuter des résultats et fournir une mise à jour générale sur l'entreprise.
Les parties intéressées peuvent accéder à l'événement via le site web de l'entreprise. Pour participer à la conférence téléphonique, une inscription est requise via un lien fourni, qui fournira un numéro d'appel et un code PIN unique. Le webinaire en direct peut être consulté via la page du Calendrier des Événements dans la section Investisseurs & News de www.exelixis.com. Un enregistrement du webinaire sera disponible sur le site de l'entreprise pendant un an.
Exelixis (Nasdaq: EXEL) hat das Veröffentlichungsdatum für die Finanzergebnisse des zweiten Quartals 2024 bekannt gegeben. Das Unternehmen wird seine finanzielle Leistung am Dienstag, dem 6. August 2024, nach Börsenschluss bekannt geben. Nach der Veröffentlichung wird das Management von Exelixis eine Konferenzschaltung und einen Webcast um 17:00 Uhr ET / 14:00 Uhr PT veranstalten, um die Ergebnisse zu besprechen und ein allgemeines Geschäftsupdate zu geben.
Interessierte Parteien können über die Unternehmenswebsite auf die Veranstaltung zugreifen. Um an der Konferenzschaltung teilzunehmen, ist eine Registrierung über einen bereitgestellten Link erforderlich, der eine Einwahlnummer und eine eindeutige PIN bereitstellt. Der Live-Webcast kann über die Seite mit dem Veranstaltungs-Kalender im Bereich Investoren & Nachrichten von www.exelixis.com abgerufen werden. Eine Aufzeichnung des Webcasts wird ein Jahr lang auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
– Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT –
To access the conference call, please register using this link. Upon registration, a dial-in number and unique PIN will be provided to join the call. To access the live webcast link, log onto www.exelixis.com and proceed to the Event Calendar page under the Investors & News heading. A webcast replay of the conference call will also be archived on www.exelixis.com for one year.
About Exelixis
Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by drug discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody-drug conjugates and other biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX® (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit www.exelixis.com, follow @ExelixisInc on X (Twitter), like Exelixis, Inc. on Facebook and follow Exelixis on LinkedIn.
Exelixis, the Exelixis logo and CABOMETYX are registered
View source version on businesswire.com: https://www.businesswire.com/news/home/20240723468114/en/
Investors Contact:
Varant Shirvanian
Director, Investor Relations
Exelixis, Inc.
650-837-7917
vshirvanian@exelixis.com
Media Contact:
Hal Mackins
For Exelixis, Inc.
415-994-0040
hal@torchcommunications.com
Source: Exelixis, Inc.
FAQ
When will Exelixis (EXEL) release its Q2 2024 financial results?
What time is the Exelixis (EXEL) Q2 2024 earnings call scheduled for?
How can I access Exelixis' (EXEL) Q2 2024 earnings call?
Where can I find the webcast for Exelixis' (EXEL) Q2 2024 financial results?
